Evidence map›Paper›PMID 35751091›Full record

Observational studyArthritis research & therapy2022

Minimal disease activity (MDA) in patients with recent-onset psoriatic arthritis: predictive model based on machine learning.

Rubén Queiro, Daniel Seoane-Mato, Ana Laiz, Eva Galíndez Agirregoikoa, Carlos Montilla, Hye-Sang Park, Jose A Pinto-Tasende, Juan J Bethencourt Baute, Beatriz Joven Ibáñez, Elide Toniolo and 3 more

Open access · goldAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Arthritis research & therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 11 institutions in 1 country.

Rubén QueiroRheumatology Service & the Principality of Asturias Institute for Health Research (ISPA), Faculty of Medicine, Universidad de Oviedo, Oviedo, Spain. rubenque7@yahoo.es.
Daniel Seoane-MatoResearch Unit, Spanish Society of Rheumatology, Madrid, Spain.
Ana LaizRheumatology and Autoimmune Disease Department, Hospital Universitari de la Santa Creu i Sant Pau, Barcelona, Spain.
Eva Galíndez AgirregoikoaRheumatology Service, Hospital Universitario Basurto, Bilbao, Spain.
Carlos MontillaRheumatology Service, Hospital Universitario de Salamanca, Salamanca, Spain.
Hye-Sang ParkRheumatology and Autoimmune Disease Department, Hospital Universitari de la Santa Creu i Sant Pau, Barcelona, Spain.
Jose A Pinto-TasendeRheumatology Service-INIBIC, Complexo Hospitalario Universitario de A Coruña, A Coruña, Spain.
Juan J Bethencourt BauteRheumatology Service, Hospital Universitario de Canarias, Sta. Cruz de Tenerife, Spain.
Beatriz Joven IbáñezRheumatology Service, Hospital Universitario 12 de Octubre, Madrid, Spain.
Elide TonioloRheumatology Service, Hospital Universitari Son Llàtzer, Palma de Mallorca, Spain.
Julio RamírezArthritis Unit, Rheumatology Department, Hospital Clínic Barcelona, Barcelona, Spain.
Ana Serrano GarcíaKnowledge Engineering Institute, Universidad Autónoma de Madrid, Madrid, Spain.
Proyecto REAPSER Study Group
Universidad Autónoma de Madrid · ESComplejo Hospitalario de Salamanca · ESHospital de Sant Pau · ESComplexo Hospitalario Universitario A Coruña · ESHospital Clínic de Barcelona · ESHospital de Basurto · ESHospital Son Llatzer · ESHospital Universitario 12 De Octubre · ESHospital Universitario de Canarias · ESSpanish Society of Hematology and Hemotherapy · ESUniversidad de Oviedo · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVery few data are available on predictors of minimal disease activity (MDA) in patients with recent-onset psoriatic arthritis (PsA). Such data are crucial, since the therapeutic measures used to change the adverse course of PsA are more likely to succeed if we intervene early. In the present study, we used predictive models based on machine learning to detect variables associated with achieving MDA in patients with recent-onset PsA.

methodsWe performed a multicenter observational prospective study (2-year follow-up, regular annual visits). The study population comprised patients aged ≥18 years who fulfilled the CASPAR criteria and less than 2 years since the onset of symptoms. The dataset contained data for the independent variables from the baseline visit and from follow-up visit number 1. These were matched with the outcome measures from follow-up visits 1 and 2, respectively. We trained a random forest-type machine learning algorithm to analyze the association between the outcome measure and the variables selected in the bivariate analysis. In order to understand how the model uses the variables to make its predictions, we applied the SHAP technique. We used a confusion matrix to visualize the performance of the model.

resultsThe sample comprised 158 patients. 55.5% and 58.3% of the patients had MDA at the first and second follow-up visit, respectively. In our model, the variables with the greatest predictive ability were global pain, impact of the disease (PsAID), patient global assessment of disease, and physical function (HAQ-Disability Index). The percentage of hits in the confusion matrix was 85.94%.

conclusionsA key objective in the management of PsA should be control of pain, which is not always associated with inflammatory burden, and the establishment of measures to better control the various domains of PsA.

Indexed as

Arthritis, PsoriaticAdolescentAdultHumansMachine LearningPainSeverity of Illness IndexTreatment OutcomeMachine learningMinimal disease activityPredictive modelRecent-onset psoriatic arthritis

Identifiers

PMID35751091
PMCPMC9229524
OpenAlexW4283375668

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.